Gerard van Hamel Platerink
Mr. van Hamel Platerink is a Managing Director and co-founder of Accuitive Medical Ventures (AMV), a $160MM early stage medical technology fund based in Atlanta, GA. AMV develops and invests in medical technologies in fields such as neurology, orthopedics and cardiology. Prior to joining AMV, Gerard worked at Novoste Corporation, the cardiovascular brachytherapy company, in business development. Before joining Novoste, Gerard was in the Healthcare Group of Salomon Smith Barney in London, where he focused on medical devices. He began his career with Kleinwort Benson (now part of Dresdner Kleinwort Wasserstein), where he was an investment banker and member of the bank's private equity and mezzanine finance group. Gerard has a BS in Physics from St. Andrews University in the UK and an MBA from Cambridge University.
Mr. van Hamel Platerink is a Managing Director and co-founder of Accuitive Medical Ventures (AMV), a $160MM early stage medical technology fund based in Atlanta, GA. AMV develops and invests in medical technologies in fields such as neurology, orthopedics and cardiology. Prior to joining AMV, Gerard worked at Novoste Corporation, the cardiovascular brachytherapy company, in business development. Before joining Novoste, Gerard was in the Healthcare Group of Salomon Smith Barney in London, where he focused on medical devices. He began his career with Kleinwort Benson (now part of Dresdner Kleinwort Wasserstein), where he was an investment banker and member of the bank's private equity and mezzanine finance group. Gerard has a BS in Physics from St. Andrews University in the UK and an MBA from Cambridge University.